头颈癌调强放疗后下颌下腺功能恢复:一项前瞻性剂量建模研究
这项前瞻性临床试验纳入90例新诊断头颈癌患者,采用动态唾液腺闪烁显像评估调强放疗后下颌下腺功能。下颌下腺排泄分数比值在12个月达最低点(15%),24个月恢复至38%,1年和2年TD50分别为36 Gy和44 Gy。
要点
- 下颌下腺排泄分数比值在放疗后12个月达最低点15%,24个月恢复至38%。
- 放疗后1年和2年的TD50分别为36 Gy和44 Gy。
- 平均剂量低于54 Gy时,每减少1 Gy,严重口干症概率降低2%–2.5%。
核心结论
- 下颌下腺功能在放疗后下降,12个月达最低点,随时间不完全恢复,24个月内持续改善。
- 放疗后1年和2年的TD50分别为36 Gy和44 Gy,平均剂量每减少1 Gy,严重口干症概率降低2%–2.5%。
研究设计与样本
- 前瞻性临床试验纳入90例新诊断头颈癌患者(T1-3、N0-2c、M0),接受治愈性图像引导放化疗。
- 采用动态唾液腺闪烁显像在基线和每6个月评估唾液毒性,共评估180个下颌下腺。
- 从剂量反应曲线估算下颌下腺TD50。
主要发现
- 180个下颌下腺的平均排泄分数比值在治疗后6个月下降,12个月达最低点(排泄分数比值15%),24个月内逐渐恢复至38%。
- 排泄分数比值与下颌下腺平均剂量呈显著负相关:6个月r=-0.18、p=0.04;12个月r=-0.36、p<0.001;18个月r=-0.48、p<0.001;24个月r=-0.42、p<0.001;超过24个月r=-0.56、p<0.001。
- 以排泄分数比值≤45%定义严重口干症,放疗后1年和2年的估计TD50分别为36 Gy和44 Gy。
- 平均剂量低于54 Gy时,每减少1 Gy,严重口干症概率降低2%–2.5%。
关键数值与推荐
- 严重口干症定义为排泄分数比值≤45%。
- 放疗后1年下颌下腺TD50为36 Gy,2年为44 Gy。
- 平均剂量低于54 Gy时,每减少1 Gy,严重口干症概率降低2%–2.5%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To estimate the dose response relationship for submandibular gland (SMG) recovery using salivary scintigraphy in patients diagnosed with head and neck cancer treated with curative image guided chemoradiation. MATERIAL AND METHODS: Ninety newly diagnosed head and neck cancer patients (T1-3, N0-2c, M0) treated with intensity modulated radiotherapy on a prospective clinical trial were assessed for salivary toxicity at predefined intervals using dynamic salivary scintigraphy. The SMG function was measured using salivary excretion fraction (SEF) ratios at baseline and 6 monthly. Tolerance dose (TD) 50 for submandibular gland was estimated from dose response curves. RESULTS: The mean SEF ratio of 180 SMGs decreased at 6 months with a nadir at 12 months after treatment (SEF ratio 15%) and progressively recovered over time reaching 38% over 24 months. There was significant inverse correlation between SEF ratio and mean SMG dose at 6 months (r = -0.18, p = 0.04); 12-months (r = -0.36, p < 0.001); 18-months (r = -0.48, p < 0.001); 24-months (r = -0.42, p < 0.001); and more than 24-months (r = -0.56, p < 0.001). The estimated TD 50 values at 1 year and 2 year post treatment were 36 Gy and 44 Gy respectively with SEF ratio of ≤45% used to define severe xerostomia. For every 1 Gy reduction in mean dose below 54 Gy, there is 2-2.5% reduction in the probability of severe xerostomia. CONCLUSION: The submandibular gland function declines after radiotherapy with a nadir at 12 months and there is incomplete recovery over time with continued improvement over 24 months. The TD 50 at 1 year and 2 year was 36 Gy and 44 Gy with a 2-2.5% reduction in the probability of severe xerostomia for every 1 Gy reduction in mean dose.
引用
- Murthy V, Lewis S, Kannan S, et al. Submandibular function recovery after IMRT in head and neck cancer: A prospective dose modelling study. Radiother Oncol. 2018. PMID: 29724411. doi:10.1016/j.radonc.2018.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。